Europe — EMA
Nuvaxovid Xbb.1.5 (Matrix M, Mivalsecovatein)
Matrix M, the active ingredient in Nuvaxovid Xbb.1.5, is a novel antiviral agent presented as a 0.5 ml prefilled syringe for intramuscular use.
Request sourcing
What is Matrix M, Mivalsecovatein?
Matrix M, the active ingredient in Nuvaxovid Xbb.1.5, is a novel antiviral agent presented as a 0.5 ml prefilled syringe for intramuscular use. It targets emerging variants of respiratory viruses in adult and pediatric populations. GNH USA supplies Nuvaxovid Xbb.1.5 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.
GNH USA supplies Nuvaxovid Xbb.1.5 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.
What is Matrix M, Mivalsecovatein used for?
Nuvaxovid Xbb.1.5 is a vaccine based on the Matrix M platform that acts on the viral‑ - COVID‑19 (Omicron XBB.1.5) : Indicates protect protect ...
What are the side effects of Matrix M, Mivalsecovatein?
Common Side Effects: - ...
